相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development
Purushottam B. Tiwari et al.
CHEMMEDCHEM (2020)
Antibiotics in the clinical pipeline in October 2019
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2020)
Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS
Szilard Pall et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Effect of tolerance on the evolution of antibiotic resistance under drug combinations
Jiafeng Liu et al.
SCIENCE (2020)
PPEF: A bisbenzimdazole potent antimicrobial agent interacts at acidic triad of catalytic domain of E. coli topoisomerase IA
Raja Singh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance
Irene Nicolas et al.
PLOS BIOLOGY (2019)
Benzimidazoles: Selective Inhibitors of Topoisomerase I with Differential Modes of Action
Sandhya Bonsal et al.
BIOCHEMISTRY (2019)
Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus
Rashmi Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Direct observation of topoisomerase IA gate dynamics
Maria Mills et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors
Xufen Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Adaptive modulation of antibiotic resistance through intragenomic coevolution
Michael J. Bottery et al.
NATURE ECOLOGY & EVOLUTION (2017)
Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains
Devapriya Sinha et al.
SCIENTIFIC REPORTS (2017)
Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents
Shayna Sandhaus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Assessing the Current State of Amber Force Field Modifications for DNA
Rodrigo Galindo-Murillo et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
Targeting Mycobacterium tuberculosis Topoisomerase I by Small-Molecule Inhibitors
Adwait Anand Godbole et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Gyramides Prevent Bacterial Growth by Inhibiting DNA Gyrase and Altering Chromosome Topology
Manohary Rajendram et al.
ACS CHEMICAL BIOLOGY (2014)
PLUMED 2: New feathers for an old bird
Gareth A. Tribello et al.
COMPUTER PHYSICS COMMUNICATIONS (2014)
Synthesis and Biological Evaluation of Novel Bisbenzimidazoles as Escherichia coli Topoisomerase IA Inhibitors and Potential Antibacterial Agents
Hemlata Nimesh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
yciM is an essential gene required for regulation of lipopolysaccharide synthesis in Escherichia coli
S. Mahalakshmi et al.
MOLECULAR MICROBIOLOGY (2014)
Roles of Type 1A Topoisomerases in Genome Maintenance in Escherichia coli
Valentine Usongo et al.
PLOS GENETICS (2014)
On the viability of Escherichia coli cells lacking DNA topoisomerase I
Anna Stockum et al.
BMC MICROBIOLOGY (2012)
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Lucia Fernandez et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
3,4-Dimethoxyphenyl bis-benzimidazole, a novel DNA topoisomerase inhibitor that preferentially targets Escherichia coli topoisomerase I
Sandhya Bansal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Antibiotic-Induced Bacterial Cell Death Exhibits Physiological and Biochemical Hallmarks of Apoptosis
Daniel J. Dwyer et al.
MOLECULAR CELL (2012)
Bacterial topoisomerase I and topoisomerase III relax supercoiled DNA via distinct pathways
Ksenia Terekhova et al.
NUCLEIC ACIDS RESEARCH (2012)
New Alkaloid Antibiotics That Target the DNA Topoisomerase I of Streptococcus pneumoniae
Maria Teresa Garcia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
All tangled up: how cells direct, manage and exploit topoisomerase function
Seychelle M. Vos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I
Amanda C. Gentry et al.
NUCLEIC ACIDS RESEARCH (2011)
A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli
Nick G. Coldham et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model
D. Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Outer membrane permeability and antibiotic resistance
Anne H. Delcour
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol
Thirunavukkarasu Annamalai et al.
BMC BIOCHEMISTRY (2009)
Efflux-Mediated Drug Resistance in Bacteria An Update
Xian-Zhi Li et al.
DRUGS (2009)
Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage
Xiao Su Pan et al.
NUCLEIC ACIDS RESEARCH (2008)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Multidrug-resistance efflux pumps - not just for resistance
Laura J. V. Piddock
NATURE REVIEWS MICROBIOLOGY (2006)
Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases
AF Zuluaga et al.
BMC INFECTIOUS DISEASES (2006)
A role for topoisomerase III in a recombination pathway alternative to RuvABC
CR Lopez et al.
MOLECULAR MICROBIOLOGY (2005)
A recipe for the computation of the free energy barrier and the lowest free energy path of concerted reactions
B Ensing et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2005)
Viability of Escherichia coli topA mutants lacking DNA topoisomerase I
VA Stupina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
C Dominguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
The acidic triad conserved in type IA DNA topoisomerases is required for binding of Mg(II) and subsequent conformational change
CX Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
